DAPTOMYCIN (DAPTOMYCIN) — FDA Approval NDA209949 (HIKMA)
DAPTOMYCIN (DAPTOMYCIN) — FDA Approval NDA209949 (HIKMA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DAPTOMYCIN; Active ingredients: DAPTOMYCIN; Application number: NDA209949.
| Brand name | DAPTOMYCIN |
|---|---|
| Active ingredients | DAPTOMYCIN |
| Application number | NDA209949 |
| Sponsor | HIKMA |
| Dosage form | POWDER |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20171020 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →